Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Arthrosi Therapeutics
Entity

Arthrosi Therapeutics

Tracked across 1 events · 8 articles · First seen Mar 18, 2026 · Last active Mar 18, 2026

Sentiment
85
Attention
4
Events
1
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 85
Business
HKSTP CTC Marketplace Showcases Biotech Success
Arthrosi Therapeutics Inc., a US-based clinical-stage biotechnology company, achieved USD 153 million in Series E funding and a subsequent acquisition valued at USD 1.5 billion. This success underscores the company's progress in developing treatments for gout.
Mar 18, 2026 · 8 articles
Relationships (4)
Nuance Pharma ↔ Arthrosi Therapeutics Unknown
Health Hope Pharma ↔ Arthrosi Therapeutics Unknown
Shunqi Yan Co-founder and COO ↔ Arthrosi Therapeutics Dr. Shunqi Yan is the Co-founder and COO of Arthrosi Therapeutics.
InxMed ↔ Arthrosi Therapeutics Unknown
NEWSDESK
Track Arthrosi Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.